Alkem Laboratories profit increased 120.31% in (Q1) FY 2020-21

Source

Team Infinities:

Alkem Laboratories Limited NSE Symbol:ALKEM, BSE Security Code:539523 has declared its 1st(first) quarter un-audited Consolidated financial report from the month of April, 2020 to the month of June, 2020; for the fiscal year 2020-21.

Revenue Reported by Alkem Laboratories Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020)Previous Quarter (January, 2020 - March, 2020)Corresponding Quarter (April, 2019 - June, 2019)
20.4720.7618.67
Calculated Revenue of Alkem Laboratories Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020)Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
0.291.40%(Revenue Decrease)1.809.64%(Revenue Increase)

Revenue: Alkem Laboratories Limited's financial report shows that the company's revenue decreased by 1.40% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for revenue decrease of Rs.0.29 billion, as the company posted revenue of Rs.20.47 billions; in compare to previous quarter(January, 2020 - March, 2020) when the company reported revenue of Rs.20.76 billions.
The result also shows that the company's revenue increased by 9.64% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for revenue increase of Rs.1.80 billions; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted revenue of Rs.18.67 billions.

Gross Margin(%) Reported by Alkem Laboratories Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020)Previous Quarter (January, 2020 - March, 2020)Corresponding Quarter (April, 2019 - June, 2019)
48.2360.0042.27
Calculated Gross Margin(%) of Alkem Laboratories Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020)Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
11.7719.61%(GM Decrease)5.9614.11%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 19.61% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for 11.77% GM decrease, as the company reported 48.23% GM; in compare to previous quarter(January, 2020 - March, 2020) when the company reported 60.00% GM.
The result also indicates, the company's GM increased by 14.11% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for 5.96% GM increase; in compare to corresponding quarter(April, 2019 - June, 2019) when the company reported 42.27% GM.

EBITDA Reported by Alkem Laboratories Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020)Previous Quarter (January, 2020 - March, 2020)Corresponding Quarter (April, 2019 - June, 2019)
5.773.312.82
Calculated EBITDA of Alkem Laboratories Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020)Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
2.4674.32%(EBITDA Increase)2.95104.61%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 74.32% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EBITDA increase of Rs.2.46 billions, as the company posted EBITDA of Rs.5.77 billions; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EBITDA of Rs.3.31 billions.
The result also shows that the company's EBITDA increased by 104.61% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EBITDA increase of Rs.2.95 billions; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EBITDA of Rs.2.82 billions.

Profit and Loss Reported by Alkem Laboratories Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020)Previous Quarter (January, 2020 - March, 2020)Corresponding Quarter (April, 2019 - June, 2019)
4.23(Profit )1.92(Profit )1.87(Profit )
Calculated Profit and Loss of Alkem Laboratories Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020)Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
2.31120.31%(Profit Increase)2.36126.20%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 120.31% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for profit increase of Rs.2.31 billions, as the company posted profit of Rs.4.23 billions; in compare to previous quarter(January, 2020 - March, 2020) when the company reported profit of Rs.1.92 billions.
The result also shows that the company's profit increased by 126.20% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for profit increase of Rs.2.36 billions; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted profit of Rs.1.87 billions.

EPS Reported by Alkem Laboratories Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020)Previous Quarter (January, 2020 - March, 2020)Corresponding Quarter (April, 2019 - June, 2019)
35.3015.7915.51
Calculated EPS of Alkem Laboratories Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020)Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
19.51123.56%(EPS Increase)19.79127.60%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 123.56% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EPS increase of Rs.19.51, as the company posted EPS of Rs.35.30; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EPS of Rs.15.79.
The result also shows that the company's EPS increased by 127.60% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EPS increase of Rs.19.79; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EPS of Rs.15.51.



***All amounts are given in Billion Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.